Format

Send to

Choose Destination
Cancer Cell. 2003 May;3(5):431-7.

Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction.

Author information

1
Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Department of Medicine, Seattle, USA.

Abstract

Adoptive T cell immunotherapy is an evolving technology with the potential of providing a means to safely and effectively target tumor cells for destruction.

PMID:
12781360
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center